Age, Initial Central Retinal Thickness, and OCT Biomarkers Have an Influence on the Outcome of Diabetic Macular Edema Treated With Ranibizumab– Tri-center 12-Month Treat-and-Extend Study

Objective: We report the tri-center 1-year outcomes of a treat-and-extend (T&E) regimen in four-week intervals with ranibizumab for diabetic macular edema (DME). Methods: In this retrospective study, all eyes received 3 monthly loading injections of 0.5 mg ranibizumab, followed by a T&E regi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Chun-Ting, Hsieh, Yi-Ting, Lin, Chun-Ju, Wang, Jia-Kang, Lin, Chih-Ying, Hsia, Ning-Yi, Bair, Henry, Chen, Huan-Sheng, Chiu, Chiung-Yi, Weng, Shao-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126636/
https://www.ncbi.nlm.nih.gov/pubmed/34012972
http://dx.doi.org/10.3389/fmed.2021.668107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126636/
https://www.ncbi.nlm.nih.gov/pubmed/34012972
http://dx.doi.org/10.3389/fmed.2021.668107

Ejemplares similares